ULK-100
ULK-100 is a potent ULK1/ULK2 inhibitor, with IC50 values of 1.6 nM and 2.6 nM against human ULK1 and ULK2, respectively. ULK-100 reduces ULK1-mediated phosphorylation of Beclin 1 at Ser15, inhibits autophagy by targeting the ULK1 pathway, and also suppresses autophagy in tumor cells. ULK-100 enhances the sensitivity of tumor cells to nutrient deprivation. ULK-100 can be used in research on autophagy initiation and cancer.
For research use only. We do not sell to patients.
- CAS No.: 945377-65-1
- Formula: C29H32F3N5O2S
- Molecular Weight:571.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
ULK1 1.6 nM (IC50) |
ULK2 2.6 nM (IC50) |
In Vitro
ULK-100 (0.06-1 μM; 1 h) dose-dependently inhibits ULK1-mediated phosphorylation of Beclin 1 Ser15 in 293FT cells expressing HA-hULK1, V5-Beclin 1 and EGFP-ATG14, with a cellular EC50 of 83 nM[1].
ULK-100 (15 nM) inhibits ULK1 activity by approximately 88% in a radiometric kinase panel containing 327 human kinases, while the inhibition level of 18 non-ULK1 kinases reaches at least 75% of that of ULK1, indicating its limited kinome selectivity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:293FT cells expressing HA-hULK1, V5-Beclin 1 and EGFP-ATG14
-
Concentration:0.06, 0.13, 0.25, 0.5 and 1 μM
-
Incubation Time:1 h
-
Result:Dose-dependently reduced Beclin 1 Ser15 phosphorylation with a cellular EC50 of 83 nM.
Chemical Information
-
CAS No. 945377-65-1
-
Molecular Weight 571.66
-
Formula C29H32F3N5O2S
-
SMILES
O=C(C1=CC(C2=C3N=CC(C4=CC=C(OCCN5CCCCC5)C=C4)=CN3N=C2)=CS1)N[C@@H](C(C)C)C(F)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (174.93 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (8.75 mM); Suspended solution
This protocol yields a suspended solution of ≥ 5 mg/mL (saturation unknown). Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
References
[1]. Martin KR, et al. A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress. iScience. 2018 Oct 26;8:74-84. [Content Brief]
[2]. Liu L, et al. A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer. Cancers. 2020 Feb 04;12(2):352. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.7493 mL | 8.7465 mL | 17.4929 mL | 43.7323 mL |
| 5 mM | 0.3499 mL | 1.7493 mL | 3.4986 mL | 8.7465 mL | |
| 10 mM | 0.1749 mL | 0.8746 mL | 1.7493 mL | 4.3732 mL | |
| 15 mM | 0.1166 mL | 0.5831 mL | 1.1662 mL | 2.9155 mL | |
| 20 mM | 0.0875 mL | 0.4373 mL | 0.8746 mL | 2.1866 mL | |
| 25 mM | 0.0700 mL | 0.3499 mL | 0.6997 mL | 1.7493 mL | |
| 30 mM | 0.0583 mL | 0.2915 mL | 0.5831 mL | 1.4577 mL | |
| 40 mM | 0.0437 mL | 0.2187 mL | 0.4373 mL | 1.0933 mL | |
| 50 mM | 0.0350 mL | 0.1749 mL | 0.3499 mL | 0.8746 mL | |
| 60 mM | 0.0292 mL | 0.1458 mL | 0.2915 mL | 0.7289 mL | |
| 80 mM | 0.0219 mL | 0.1093 mL | 0.2187 mL | 0.5467 mL | |
| 100 mM | 0.0175 mL | 0.0875 mL | 0.1749 mL | 0.4373 mL |